Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jun;115(3):401–408. doi: 10.1111/j.1476-5381.1995.tb16347.x

Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide.

P Akarasereenont 1, Y S Bakhle 1, C Thiemermann 1, J R Vane 1
PMCID: PMC1908422  PMID: 7582449

Abstract

1. The induction of cyclo-oxygenase-2 (COX-2) afforded by bacterial lipopolysaccharide (LPS, endotoxin) in bovine aortic endothelial cells (BAEC) is mediated by tyrosine kinase. LPS also causes the generation of several cytokines including interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), epidermal growth factor (EGF) and platelet-derived growth factor (PDGF). This study investigates whether endogenous IL-1 beta, TNF-alpha, EGF or PDGF contribute to the induction of COX-2 elicited by LPS in BAEC and if their action is due to activation of tyrosine kinase. Furthermore, we have studied the induction of COX-2 by exogenous cytokines. 2. Accumulation of 6-oxo-prostaglandin (PG) F1 alpha in cultures of BAEC was measured by radioimmunoassay at 24 h after addition of either LPS (1 microgram ml-1) alone or LPS together with a polyclonal antibody to one of the various cytokines. In experiments designed to measure 'COX activity', 6-oxo-PGF1 alpha generated by BAEC activated with recombinant human IL-1 beta, TNF-alpha, EGF or PDGF for 12 h was measured after incubation of washed cells with exogenous arachidonic acid (30 microM for 15 min). Western blot analysis determined the expression of COX-2 protein in BAEC. 3. The accumulation of 6-oxo-PGF1 alpha caused by LPS in BAEC was attenuated by co-incubation with one of the polyclonal antibodies, anti-IL-1 beta, anti-TNF-alpha, anti-EGF, anti-PDGF or with the IL-1 receptor antagonist, in a dose-dependent manner. Exogenous IL-1 beta, TNF-alpha or EGF also caused an increase in COX activity, while PDGF was ineffective.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
401

Images in this article

404Figure 4
on p.404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akarasereenont P., Mitchell J. A., Appleton I., Thiemermann C., Vane J. R. Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells. Br J Pharmacol. 1994 Dec;113(4):1522–1528. doi: 10.1111/j.1476-5381.1994.tb17169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akarasereenont P., Mitchell J. A., Bakhle Y. S., Thiemermann C., Vane J. R. Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur J Pharmacol. 1995 Jan 24;273(1-2):121–128. doi: 10.1016/0014-2999(94)00680-6. [DOI] [PubMed] [Google Scholar]
  3. Albelda S. M., Elias J. A., Levine E. M., Kern J. A. Endotoxin stimulates platelet-derived growth factor production from cultured human pulmonary endothelial cells. Am J Physiol. 1989 Aug;257(2 Pt 1):L65–L70. doi: 10.1152/ajplung.1989.257.2.L65. [DOI] [PubMed] [Google Scholar]
  4. Corbett J. A., Sweetland M. A., Lancaster J. R., Jr, McDaniel M. L. A 1-hour pulse with IL-1 beta induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: evidence for a tyrosine kinase signaling mechanism. FASEB J. 1993 Feb 1;7(2):369–374. doi: 10.1096/fasebj.7.2.8440413. [DOI] [PubMed] [Google Scholar]
  5. Cordle S. R., Donald R., Read M. A., Hawiger J. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. J Biol Chem. 1993 Jun 5;268(16):11803–11810. [PubMed] [Google Scholar]
  6. Donato N. J., Gallick G. E., Steck P. A., Rosenblum M. G. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity. J Biol Chem. 1989 Dec 5;264(34):20474–20481. [PubMed] [Google Scholar]
  7. Endo H., Akahoshi T., Kashiwazaki S. Additive effects of IL-1 and TNF on induction of prostacyclin synthesis in human vascular endothelial cells. Biochem Biophys Res Commun. 1988 Oct 31;156(2):1007–1014. doi: 10.1016/s0006-291x(88)80944-6. [DOI] [PubMed] [Google Scholar]
  8. Fletcher J. R. Eicosanoids. Critical agents in the physiological process and cellular injury. Arch Surg. 1993 Nov;128(11):1192–1196. doi: 10.1001/archsurg.1993.01420230020003. [DOI] [PubMed] [Google Scholar]
  9. Floege J., Topley N., Wessel K., Kaever V., Radeke H., Hoppe J., Kishimoto T., Resch K. Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney Int. 1990 Mar;37(3):859–869. doi: 10.1038/ki.1990.59. [DOI] [PubMed] [Google Scholar]
  10. Goldblum S. E., Brann T. W., Ding X., Pugin J., Tobias P. S. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J Clin Invest. 1994 Feb;93(2):692–702. doi: 10.1172/JCI117022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hajjar K. A., Hajjar D. P., Silverstein R. L., Nachman R. L. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med. 1987 Jul 1;166(1):235–245. doi: 10.1084/jem.166.1.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henderson B., Blake S. Therapeutic potential of cytokine manipulation. Trends Pharmacol Sci. 1992 Apr;13(4):145–152. doi: 10.1016/0165-6147(92)90052-8. [DOI] [PubMed] [Google Scholar]
  13. Hewett J. A., Roth R. A. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev. 1993 Dec;45(4):382–411. [PubMed] [Google Scholar]
  14. Imoto M., Umezawa K., Isshiki K., Kunimoto S., Sawa T., Takeuchi T., Umezawa H. Kinetic studies of tyrosine kinase inhibition by erbstatin. J Antibiot (Tokyo) 1987 Oct;40(10):1471–1473. doi: 10.7164/antibiotics.40.1471. [DOI] [PubMed] [Google Scholar]
  15. Iwasaki T., Uehara Y., Graves L., Rachie N., Bomsztyk K. Herbimycin A blocks IL-1-induced NF-kappa B DNA-binding activity in lymphoid cell lines. FEBS Lett. 1992 Feb 24;298(2-3):240–244. doi: 10.1016/0014-5793(92)80067-q. [DOI] [PubMed] [Google Scholar]
  16. Kawakami M., Ishibashi S., Ogawa H., Murase T., Takaku F., Shibata S. Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun. 1986 Dec 15;141(2):482–487. doi: 10.1016/s0006-291x(86)80198-x. [DOI] [PubMed] [Google Scholar]
  17. Kobayashi E., Nakano H., Morimoto M., Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989 Mar 15;159(2):548–553. doi: 10.1016/0006-291x(89)90028-4. [DOI] [PubMed] [Google Scholar]
  18. Kohno M., Nishizawa N., Tsujimoto M., Nomoto H. Mitogenic signalling pathway of tumour necrosis factor involves the rapid tyrosine phosphorylation of 41,000-Mr and 43,000-Mr cytosol proteins. Biochem J. 1990 Apr 1;267(1):91–98. doi: 10.1042/bj2670091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O., Takahashi E., Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 1994 May 1;221(3):889–897. doi: 10.1111/j.1432-1033.1994.tb18804.x. [DOI] [PubMed] [Google Scholar]
  20. Kurt-Jones E. A., Fiers W., Pober J. S. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol. 1987 Oct 1;139(7):2317–2324. [PubMed] [Google Scholar]
  21. Lee S. H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992 Dec 25;267(36):25934–25938. [PubMed] [Google Scholar]
  22. Levitzki A. Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB J. 1992 Nov;6(14):3275–3282. doi: 10.1096/fasebj.6.14.1426765. [DOI] [PubMed] [Google Scholar]
  23. Libby P., Ordovas J. M., Auger K. R., Robbins A. H., Birinyi L. K., Dinarello C. A. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol. 1986 Aug;124(2):179–185. [PMC free article] [PubMed] [Google Scholar]
  24. Lin A. H., Bienkowski M. J., Gorman R. R. Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor. J Biol Chem. 1989 Oct 15;264(29):17379–17383. [PubMed] [Google Scholar]
  25. Maier J. A., Hla T., Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem. 1990 Jul 5;265(19):10805–10808. [PubMed] [Google Scholar]
  26. Maier J. A., Voulalas P., Roeder D., Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science. 1990 Sep 28;249(4976):1570–1574. doi: 10.1126/science.2218499. [DOI] [PubMed] [Google Scholar]
  27. Mantovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 1992 May;6(8):2591–2599. doi: 10.1096/fasebj.6.8.1592209. [DOI] [PubMed] [Google Scholar]
  28. Marczin N., Papapetropoulos A., Catravas J. D. Tyrosine kinase inhibitors suppress endotoxin- and IL-1 beta-induced NO synthesis in aortic smooth muscle cells. Am J Physiol. 1993 Sep;265(3 Pt 2):H1014–H1018. doi: 10.1152/ajpheart.1993.265.3.H1014. [DOI] [PubMed] [Google Scholar]
  29. Martich G. D., Boujoukos A. J., Suffredini A. F. Response of man to endotoxin. Immunobiology. 1993 Apr;187(3-5):403–416. doi: 10.1016/S0171-2985(11)80353-0. [DOI] [PubMed] [Google Scholar]
  30. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693–11697. doi: 10.1073/pnas.90.24.11693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Morrison D. C., Ryan J. L. Bacterial endotoxins and host immune responses. Adv Immunol. 1979;28:293–450. doi: 10.1016/s0065-2776(08)60802-0. [DOI] [PubMed] [Google Scholar]
  32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  33. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 1994 May 27;264(5163):1319–1322. doi: 10.1126/science.8191285. [DOI] [PubMed] [Google Scholar]
  34. Palkama T., Majuri M. L., Mattila P., Hurme M., Renkonen R. Regulation of endothelial adhesion molecules by ligands binding to the scavenger receptor. Clin Exp Immunol. 1993 May;92(2):353–360. doi: 10.1111/j.1365-2249.1993.tb03404.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pober J. S., Cotran R. S. Cytokines and endothelial cell biology. Physiol Rev. 1990 Apr;70(2):427–451. doi: 10.1152/physrev.1990.70.2.427. [DOI] [PubMed] [Google Scholar]
  36. Pomerantz K. B., Summers B., Hajjar D. P. Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells. Evidence for reduced posttranscriptional processing of cyclooxygenase I and reduced cyclooxygenase II gene expression. Biochemistry. 1993 Dec 14;32(49):13624–13635. doi: 10.1021/bi00212a030. [DOI] [PubMed] [Google Scholar]
  37. Pugin J., Schürer-Maly C. C., Leturcq D., Moriarty A., Ulevitch R. J., Tobias P. S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2744–2748. doi: 10.1073/pnas.90.7.2744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pusztai L., Lewis C. E., Lorenzen J., McGee J. O. Growth factors: regulation of normal and neoplastic growth. J Pathol. 1993 Feb;169(2):191–201. doi: 10.1002/path.1711690204. [DOI] [PubMed] [Google Scholar]
  39. Read M. A., Cordle S. R., Veach R. A., Carlisle C. D., Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9887–9891. doi: 10.1073/pnas.90.21.9887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ristimäki A., Ylikorkala O., Perheentupa J., Viinikka L. Epidermal growth factor stimulates prostacyclin production by cultured human vascular endothelial cells. Thromb Haemost. 1988 Apr 8;59(2):248–250. [PubMed] [Google Scholar]
  41. Salmon J. A. A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins. 1978 Mar;15(3):383–397. doi: 10.1016/0090-6980(78)90122-3. [DOI] [PubMed] [Google Scholar]
  42. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7240–7244. doi: 10.1073/pnas.90.15.7240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Suzuki H., Shibano K., Okane M., Kono I., Matsui Y., Yamane K., Kashiwagi H. Interferon-gamma modulates messenger RNA levels of c-sis (PDGF-B chain), PDGF-A chain, and IL-1 beta genes in human vascular endothelial cells. Am J Pathol. 1989 Jan;134(1):35–43. [PMC free article] [PubMed] [Google Scholar]
  44. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun. 1986 Mar 13;135(2):397–402. doi: 10.1016/0006-291x(86)90008-2. [DOI] [PubMed] [Google Scholar]
  45. Thiemermann C. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol. 1994;28:45–79. doi: 10.1016/s1054-3589(08)60493-7. [DOI] [PubMed] [Google Scholar]
  46. Tracey K. J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317–343. doi: 10.1146/annurev.cb.09.110193.001533. [DOI] [PubMed] [Google Scholar]
  47. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  48. Wheeler A. P., Hardie W. D., Bernard G. R. The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep. Am Rev Respir Dis. 1992 Mar;145(3):632–639. doi: 10.1164/ajrccm/145.3.632. [DOI] [PubMed] [Google Scholar]
  49. Wilson S. E., Schultz G. S., Chegini N., Weng J., He Y. G. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994 Jul;59(1):63–71. doi: 10.1006/exer.1994.1081. [DOI] [PubMed] [Google Scholar]
  50. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]
  51. Xie W. L., Chipman J. G., Robertson D. L., Erikson R. L., Simmons D. L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2692–2696. doi: 10.1073/pnas.88.7.2692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Zavoico G. B., Ewenstein B. M., Schafer A. I., Pober J. S. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. J Immunol. 1989 Jun 1;142(11):3993–3999. [PubMed] [Google Scholar]
  53. de Nucci G., Gryglewski R. J., Warner T. D., Vane J. R. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2334–2338. doi: 10.1073/pnas.85.7.2334. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES